HSBC Holdings
OYST

HSBC Holdings’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

HSBC Holdings’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-103,510
Closed -$449K – 3387
2022
Q2 		$449K Hold
103,510
– – ﹤0.01% 2383
2022
Q1 		$1.21M Sell
103,510
-2,664
-3% -$31.7K ﹤0.01% 1836
2021
Q4 		$1.94M Buy
106,174
+39,770
+60% +$505K ﹤0.01% 1701
2021
Q3 		$790K Buy
+66,404
New +$967K ﹤0.01% 2008

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HSBC Holdings's OYST Position: Q3 2022 in Review

HSBC Holdings sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2022, closing a stake of 103,510 shares — an estimated $449K sold.

HSBC Holdings first reported a position in OYST in Q3 2021 and held it in 4 quarters. The position peaked at $1.94M in Q4 2021. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

  • HSBC Holdings reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HSBC Holdings sold 103,510 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022, an estimated $449K.
  • HSBC Holdings first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • HSBC Holdings's Oyster Point Pharma, Inc. Common Stock position peaked at $1.94M in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.